PT Biofarma, holding company for state pharmaceuticals, has agreed to provide Rp846 billion shareholder’s loan to the troubled subsidiary PT Kimia Farma Tbk (KAEF). KAEF, which would be merged with fellow troubled state pharmaceutical Indofarma (INAF), will use the loan to strengthen its working capital. To subscribe please click here
